Larvol Delta - OBI-Pharma-granted-US-FDA-Orphan-Drug-Designation-for-the-treatment-of-gastric-cancer-for-its-antibodydrug-conjugate-ADC-targeted-cancer-therapy-OBI999

OBI-999 - OBI Pharma

https://www.prnewswire.com/news-releases/obi-pharma-granted-us-fda-orphan-drug-designation-for-the-treatment-of-gastric-cancer-for-its-antibody-drug-conjugate-adc-targeted-cancer-therapy-obi-999-300989984.html

Jan 21, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next